Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes

Carcinogenesis

Volumn 28, Issue 7, 2007, Pages 1520-1525

  Breton, Carrie V ^a   Zhou, Wei ^a   Kile, Molly L ^a   Houseman, E A ^b   Quamruzzaman, Quazi ^c   Rahman, Mahmuder ^c   Mahiuddin, Golam ^c   Christiani, David C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c Dhaka Community Hospital   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

APURINIC ENDONUCLEASE; APYRIMIDINIC ENDONUCLEASE; ARGININE; ARSENIC; ASPARTIC ACID; CYTOSINE; DNA GLYCOSYLTRANSFERASE; ENDONUCLEASE; GLUCAGON; GLUTAMIC ACID; HUMAN 8 HYDROXYGUANINE DNA GLYCOSYLTRANSFERASE; SCAFFOLD PROTEIN; SERINE; TRYPSIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING GROUP 1;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARSENIC POISONING; ARTICLE; BANGLADESH; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA REPAIR; ENVIRONMENTAL EXPOSURE; EXCISION REPAIR; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; KERATOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOSIS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN DEFECT;

ADOLESCENT; ADULT; ARSENIC; CASE-CONTROL STUDIES; DNA REPAIR; ENVIRONMENTAL POLLUTANTS; FEMALE; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NAILS; ODDS RATIO; POLYMORPHISM, GENETIC; SKIN NEOPLASMS; TOES;

EID: 34547824703     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm063     Document Type: Article

References (54)

1. Bates,M.N. et al. (1992) Arsenic ingestion and internal cancers: A review. Am. J. Epidemiol., 135, 462-476.
2. Szymanska-Chabowska,A. et al. (2002) Some aspects of arsenic toxicity and carcinogenicity in living organism with special regard to its influence on cardiovascular system, blood and bone marrow. Int. J. Occup. Med. Environ. Health, 15, 101-116.
3. Centeno,J.A. et al. (2002) Pathology related to chronic arsenic exposure. Environ. Health Perspect., 110, (suppl. 5), 883-886.
4. Khan,M.M. et al. (2003) Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: Evidence from a review of the literature. Asian Pac. J. Cancer Prev., 4, 7-14.
5. Yoshida,T. et al. (2004) Chronic health effects in people exposed to arsenic via the drinking water: Dose-response relationships in review. Toxicol. Appl. Pharmacol., 198, 243-252.
6. Yu,H.S. et al. (2006) Arsenic carcinogenesis in the skin. J. Biomed. Sci., 13, 657-666.
7. Huang,C. et al. (2004) Molecular mechanisms of arsenic carcinogenesis. Mol. Cell Biochem., 255, 57-66.
8. Hartwig,A. et al. (1997) Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis, 18, 399-405.
9. Schwerdtle,T. et al. (2003) Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair (Amst.), 2, 1449-1463.
10. Witkiewicz-Kucharczyk,A. et al. (2006) Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol. Lett., 162, 29-42.
11. Snow,E.T. et al. (2005) Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk? Toxicol. Appl. Pharmacol., 207, 557-564.
12. Frosina,G. (2004) Commentary: DNA base excision repair defects in human pathologies. Free Radic. Res., 38, 1037-1054.
13. Hu,Z. et al. (2005) XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev., 14, 1810-1818.
14. Cooke,M.S. et al. (2005). DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat. Res., 574, 58-66.
15. Banerjee,M. et al. (2006) Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations. Carcinogenesis, doi:10.1093/ carcin/bgl181.
16. Ding,W. et al. (2005) Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol. Cell Biochem., 279, 105-112.
17. Shi,H. et al. (2004) Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell Biochem., 255, 67-78.
18. Caldecott,K.W. (2003) XRCC1 and DNA stand break repair. DNA Repair (Amst.), 2, 955-969.
19. Shibutani,S. et al. (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, 349 431-434.
20. Vodicka,P. et al. (2007) Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis, 28, 657-664.
21. Goode,E.L. et al. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1513-1530.
22. Weiss,J.M. et al. (2005) Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature. Mol. Carcinog., 42, 127-141.
23. Vogel,U. et al. (2004) No association between OGG1 Ser326Cys and risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 13, 1680-1681.
24. Nelson,H.H. et al. (2002) The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: Evidence of gene-environment interaction. Cancer Res., 62, 152-155.
25. Han,J. et al. (2004) Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br. J. Cancer, 91, 1604-1609.
26. Hung,R.J. et al. (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am. J. Epidemiol., 162, 925-942.
27. Kunisada,M. et al. (2005) 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis. Cancer Res., 65, 6006-6010.
28. Hamadeh,H.K. et al. (2002) Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol. Sci., 69, 306-316.
29. Nishigori,C. et al. (2004) Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox. Signal., 6, 561-570.
30. Ahsan,H. et al. (2000) Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J. Occup. Environ. Med., 42, 1195-1201.
31. Rahman,M. et al. (2006) Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab, Bangladesh. J. Epidemiol. Community Health, 60, 242-248.
32. Fewtrell,L. et al. (2005) An estimation of the global burden of disease due to skin lesions caused by arsenic in drinking water. J. Water Health, 3, 101-107.
33. British Geological Survey et al. (2001) Arsenic contamination of the groundwater. Vol. II. In: Kinniburgh,D.G. and Smedley,P.L. (eds). British Geologic Survey and Bangladesh Department of Public Health and Engineering. Keyworth, UK.
34. Greenland,S. (1993) Basic problems in interaction assessment. Environ. Health Perspect., 101 (suppl. 4). 59-66.
35. Chen,K.L. et al. (1999) Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol. Trace Elem. Res., 67, 109-125.
36. Breton,C.V. et al. (2006) Gender-specific protective effect of hemoglobin on arsenic-induced skin lesions. Cancer Epidemiol. Biomarkers Prev., 15, 902-907.
37. Kile,M. et al. (2005) Toenail arsenic concentrations, GSTT1 gene polymorphisms, and arsenic exposure from drinking water. Cancer Epidemiol. Biomarkers Prev., 14, 2419-2426.
38. Karagas,M.R. et al. (2000) Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations. Am. J. Epidemiol., 152, 84-90.
39. Ruppert,D. et al. (2003) Semiparametric Regression. Cambridge University Press, Cambridge, UK.
40. Hastie,T.J. et al. (1990) Generalized Additive Models. Chapman and Hall, New York.
41. Piegorsch,W.W. et al. (1994) Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat. Med., 13, 153-162.
42. Khoury,M.J. et al. (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls!. Am. J. Epidemiol., 144, 207-213.
43. Ito,H. et al. (2004) Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis, 25, 1395-1401.
44. Popanda,O. et al. (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis, 25, 2433-2441.
45. Hu,J.J. et al. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis, 22, 917-922.
46. Wang,Y. et al. (2003) From genotype to phenotype: Correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst.), 2, 901-908.
47. Zienolddiny,S. et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-567.
48. Lunn,R.M. et al. (1999) XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res., 59, 2557-2561.
49. Winsey,S.L. et al. (2000) A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res., 60, 5612-5616.
50. Hadi,M.Z. et al. (2000) Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res., 28, 3871-3879.
51. Wilson,D.M.3rd et al. (2001) The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat. Res., 485, 283-307.
52. Demple,B. et al. (2005) Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst.), 4, 442-449.
53. Botto,L.D. et al. (2001) Commentary: Facing the challenge of gene-environment interaction: The two-by-four table and beyond. Am. J. Epidemiol., 153, 1016-1020.
54. Rossman,T.G. et al. (2001) Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol., 176, 64-71.